Login
From:
Drug Discovery and Development
(Uncensored)
subscribe
Parallel Bio's $21M in Series A will drive aim to cut $2B and 9 years from drug development
https://www.drugdiscoverytrends.com/parallel-bios-21m-in-series-a-will-drive-aim-to-slash-2b-and-9-years-from-drug-development-timelines/
links
backlinks
Tagged with:
uncategorized
Cambridge-based biotechnology company Parallel Bio has closed a $21 million Series A funding round led by AIX Ventures.
Roast topics
Find topics
Find it!
